Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2007

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
This open-label, repeat dosing study, TRA108057, will evaluate the efficacy, safety and tolerability of eltrombopag, when administered in a repeat, cyclic dosing schedule. The study will describe the effect of repeated (3 cycles), intermittent dosing of eltrombopag on the pharmacodynamics and durability of eltrombopag response as measured by the peripheral platelet counts.

For more information or to see if you qualify, please visit: http://www.itpstudy.com/gov
Epistemonikos ID: 5d733a58abcfbc25523a651653bc2506cede7f9b
First added on: May 04, 2024